Related references
Note: Only part of the references are listed.Suppression of hyaluronan synthase 2 expression reflects the atrophogenic potential of glucocorticoids
Marco Averbeck et al.
EXPERIMENTAL DERMATOLOGY (2010)
Imatinib mesylate inhibits proliferation and exerts an antifibrotic effect in human breast stroma fibroblasts
Vassiliki Gioni et al.
MOLECULAR CANCER RESEARCH (2008)
Glucocorticoid therapy-induced skin atrophy
S Schoepe et al.
EXPERIMENTAL DERMATOLOGY (2006)
The impact of chronic in vivo glucocorticoid excess on the functional characteristics of human skin fibroblasts obtained from patients with endogenous Cushing's syndrome
I Zervolea et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Long-term in vivo administration of glucocorticoid hormones attenuates their capacity to accelerate in vitro proliferation of rat splenic T cells
P Sterzer et al.
ENDOCRINOLOGY (2004)
Extension of replicative lifespan in WI-38 human fibroblasts by dexamethasone treatment is accompanied by suppression of p21Waf1/Cip1/Sdi1 levels
M Mawal-Dewan et al.
EXPERIMENTAL CELL RESEARCH (2003)
Modulation of collagen synthesis and mRNA by continuous and intermittent use of topical hydrocortisone in human skin
P Nuutinen et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Chronic in vivo exposure to glucocorticoids prolongs cellular lifespan: the case of Cushing's syndrome-patients' fibroblasts
H Pratsinis et al.
EXPERIMENTAL GERONTOLOGY (2002)
Minireview:: 11β-hydroxysteroid dehydrogenase type 1 -: A tissue-specific amplifier of glucocorticoid action
JR Seckl et al.
ENDOCRINOLOGY (2001)
Share Paper
